Symposium on immunity and the heart
Autoimmunity to the heart in cardiac disease: Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies

https://doi.org/10.1016/0002-9149(69)90489-5Get rights and content

Abstract

Current information on the role of immune mechanisms in rheumatic fever, postcardiotomy and postinfarction syndromes, cardiomyopathies and other cardiac disorders is reviewed. The possible role of autoimmunity is emphasized in view of the evidence that serum autoantibodies to diverse constituents of heart tissue frequently may be detected in these cardiac disorders.

In rheumatic fever, experimental and clinical data indicate that autoimmunity to heart tissue may be induced in response to a constituent of group A streptococci, antigenically cross-reactive with heart tissue. Populations of autoantibodies with divergent specificities are present in the sera of patients with rheumatic disease. Certain of these autoantibodies exhibit correlation with the severity of disease and with the presence of carditis. The differentiation of those autoantibodies reactive with streptococcal crossreactive antigen seems essential for further understanding of the possible role of autoimmunity in pathogenesis. Evidence for such a role is provided by immunopathologic findings of bound gamma globulin and complement in postmortem rheumatic hearts and in biopsy specimens of atrial appendage.

Circulating autoantibodies to heart tissue occur frequently after cardiotomy and myocardial infarction and are commonly associated with postcardiotomy and postmyocardial infarction syndromes. They may reappear during symptomatic recurrent episodes but are not present in quiescent intervals between attacks. Further efforts should be directed to definition of the specific antigens stimulating such autoantibodies, to the biologic and physicochemical properties of the autoantibodies related to clinical symptoms, as well as to immunopathologic observations in these syndromes.

In recurrent acute benign pericarditis and in primary cardiomyopathies, viral infection, complicated by hypersensitivity or autoimmunity, or both, has been proposed as a pathogenetic mechanism. Autoimmune bodies have been described in varying frequency in these conditions, and their possible role in pathogenesis should be investigated further, using combined immunologie, virologie and immunopathologic approaches in the early phases of disease.

Abnormal immune mechanisms are strongly suspect in the pathogenesis of the cardiac involvement of rheumatoid arthritis, systemic lupus and polyarteritis, but progress must await further understanding of the cause of the primary lesions in these conditions.

In tropical endomyocardial fibrosis, an abnormal autoimmunologic diathesis, presumptively related to malarial infection, has been implicated.

Animal models of autoimmune myocarditis have been explored. The available data suggest that experimental cardiac lesions of a focal nature may be produced in a variety of animal species. Their relevance as a model for human cardiac disease is under current study.

References (71)

  • A.M. Weintraub et al.

    The occurrence of valvular and myocardial disease in patients with chronic joint deformity

    Am. J. Med.

    (1963)
  • C. Steffen et al.

    Untersuchungen über die Eigenschaften einer im Serum von Polyarthritikern and von Patienten mit rheumatischer Endokarditis vorkommenden Substanz mit den Merkmalen eines gewebsspezifischen Antikörpers

    Schweiz. Ztschr. path. Bact.

    (1955)
  • C. Krishnan et al.

    Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of γ-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis

    J. Clin. Invest.

    (1967)
  • H. Brokman et al.

    Komplement Ablenkung mit Organ Extrakten von Rheumatikern—B. B.F.—Reaktion bei sogenanntem akuten Gelenk-rheumatismus

    Klin. Wchnschr.

    (1937)
  • P.A. Cavelti

    Autoantibodies in rheumatic fever

  • V. Wagner et al.

    Response by antibodies to tissue antigens in the course of rheumatic fever

    Ann. Rheumat. Dis.

    (1956)
  • M.H. Kaplan

    Autoantibodies to heart tissue in the sera of certain patients with rheumatic fever

    M.H. Kaplan

    The concept of autoantibodies in rheumatic fever and in the post-commissurotomy state

    Ann. New York Acad. Sc.

    (1960)
  • M.H. Kaplan et al.

    Immunologic studies of heart tissue. IV. Serologic reactions with human heart tissue as revealed by immunofluorescent methods: isoimmune, Wassermann, and autoimmune reactions

    J. Exper. Med.

    (1961)
  • E.V. Hess et al.

    Heart muscle antibodies in rheumatic fever and other diseases

    J. Clin. Invest.

    (1964)
  • D. Zitnan et al.

    Antimyocardial serum factors in rheumatic fever detected by the immunofluorescence method

    Acta rheumat. scandinav.

    (1966)
  • K. Polzer et al.

    Weitere Untersuchungen über die klinische Verwertbarkeit des Antiglobulin-Konsumptionstestes bei Rheumatischen Herzerkrankungen

    Klin. Wchnschr.

    (1958)
  • G.R. Burgio et al.

    Antibodies reacting with heart tissue in the course of rheumatic fever in children

    Schweiz. med. Wchnschr.

    (1966)
  • G. Felsh

    The anti-globulin consumption test in rheumatic carditis

    Deutsche med. Wchnschr.

    (1966)
    G. Felsh

    German Med. Monthly

    (1967)
  • E.N. Ehrenfeld et al.

    Specific antibodies in heart disease

    Lancet

    (1961)
  • A.G. Osler et al.

    Fixation of complement by human sera and alcoholic extracts of human cardiac tissue

    Am. J. Syph.

    (1954)
  • K.O. Vorlaender

    Weitere Untersuchungen zur Frage der klinische Bedeutung von Auto-antikörpernachweisen beim Rheumatismus und bei entzündlichen Organerkrankungen

    Ztschr. ges. exper. Med.

    (1952)
  • J.B. Zabriskie

    Mimetic relationships between group A streptococci and mammalian tissues

    Advances Immunol.

    (1967)
  • V.N. Dodson et al.

    Certain immunologic substances in the serum of patients with myocardial infarction and other cardiovascular diseases

    Am. Heart J.

    (1967)
  • Kaplan, M. H. Unpublished...
  • B.F. Massell et al.

    Rheumatic fever following streptococcal vaccination

    J.A.M.A.

    (1969)
  • M.H. Kaplan et al.

    Immunologic relation of streptococcal and tissue antigens. II. Cross-reaction of antisera to mammalian heart tissue with a cell wall constituent of certain strains of group A streptococci

    J. Exper. Med.

    (1964)
  • I.M. Lyampert et al.

    Study on streptococcus group A antigens common with heart tissue elements

    Immunology

    (1966)
  • T.A. Danilova

    An immunofluorescent study of the antigen of group A streptococcus and heart tissue from human and experimental animals

  • L.S. Nakhla et al.

    Studies on the antigen in β-hemolytic streptococci that crossreacts with an antigen in human myocardium

    Immunology

    (1967)
  • J.B. Zabriskie et al.

    An immunological relationship between the group A streptococcus and mammalian muscle

    J. Exper. Med.

    (1966)
  • Cited by (99)

    • Organ-Specific Autoimmune Myocardial Diseases: From Pathogenesis to Diagnosis and Management

      2017, The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches
    • Organ-Specific Autoimmunity Involvement in Cardiovascular Disease

      2017, Handbook of Systemic Autoimmune Diseases
      Citation Excerpt :

      In addition, shared epitopes have been reported between N-acetyl-glucosamine of the mid-parietal streptococcus cell layer and glycoproteins of mammalian cardiac valve tissue, and another cross-reaction has been found between streptococcal hyaluronate and protein polysaccharide of mammalian cartilage (Robinson and Kehoe, 1992). In addition, antistreptococcal antibodies, cross-reactive with heart antigens and thalamus and subthalamus components, have been found in some patients with carditis and chorea (reviewed by Kaplan and Frengley, 1969). The heart cross-reactive antistreptococcal antibodies, identified by a combination of immunofluorescent and precipitin-absorption techniques, were present in 55% and 58% of patients with active and inactive rheumatic heart disease, respectively, or with acute glomerulonephritis in 24% of patients with recent streptococcal infection and only rarely (2%) in disease controls without rheumatic heart disease or previous streptococcal infection, but the pathogenetic significance of these antibodies remained to be evaluated (Kaplan and Svec, 1964).

    • Relation of Antimyocardium Antibodies to Mortality in Patients with Acute Myocardial Infarction

      2006, Archives of Medical Research
      Citation Excerpt :

      In some cardiovascular pathologies, antimyocardium antibodies (AMA) have been identified as in dilated cardiomyopathy and other heart conditions (1–5) including patients with acute myocardial infarction (AMI) (6–8).

    • Organ-Specific Autoimmunity Involvement in Cardiovascular Disease

      2003, Handbook of Systemic Autoimmune Diseases
      Citation Excerpt :

      Several methods were used, in the earliest studies, for detection of circulating anti-heart autoantibodies in rheumatic fever. These (reviewed by Kaplan and Frengley, 1969) were later abandoned and included: agglutination tests with collodion particles coated with saline extracts of the heart and other organs, CFT with saline extracts of the heart, liver and spleen, tanned red cell hemagglutination test and anti-globulin consumption with heart homogenate. Subsequently, s-I IFL on cryostat-cut sections became the method of choice; however, tissue substrates were various and included: human or rat myocardium (Van der Geld, 1964), normal human myocardium obtained at autopsy or surgery in subjects with congenital heart defects (Zabriskie et al., 1970; Engle et al., 1974), normal human myocardium of O blood group, obtained at surgery in subjects with congenital heart defects (Maisch et al., 1979).

    View all citing articles on Scopus

    Research Career Awardee, U. S. Public Health Grant K6-HE-4576 and supported by U. S. Public Health Grant H-3726.

    View full text